ResearcherTokyo Medical UniversityActive in the last 2 years
Koichi Tokuuye
Matched on ORCID iD 0000-0001-9241-7097; OpenAlex author ID A5054103406. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- Safe Proton Beam Re-irradiation With a Bioabsorbable Spacer in Pancreatic Cancer: A Case Report. First author DOI 10.1016/j.ijpt.2026.101311↗
- Initial Experience With Proton Beam Therapy for Pancreatic Cancer at Shonan Kamakura General Hospital. Co-author DOI 10.21873/invivo.14101↗
- A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic … Co-author DOI 10.1007/s00280-017-3288-7↗
- Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. Last author DOI 10.3892/mco.2015.664↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shintaro Shiba · 2 shared papers, 2025–2026 · strength 0.60
- Motoko Omura · 2 shared papers, 2025–2026 · strength 0.60
- Hiroki Yamaue · 1 shared paper, 2026 · strength 0.32
- Yuichi Hosokawa · 2 shared papers, 2016–2017 · strength 0.12
- Paper A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S… DOI 10.1007/s00280-017-3288-7↗
- Paper Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. DOI 10.3892/mco.2015.664↗
- Yuichi Nagakawa · 2 shared papers, 2016–2017 · strength 0.12
- Paper A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S… DOI 10.1007/s00280-017-3288-7↗
- Paper Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. DOI 10.3892/mco.2015.664↗
- Akihiko Tsuchida · 2 shared papers, 2016–2017 · strength 0.12
- Paper A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S… DOI 10.1007/s00280-017-3288-7↗
- Paper Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. DOI 10.3892/mco.2015.664↗
- Kazuhiko Kasuya · 1 shared paper, 2017 · strength 0.06
- Norifumi Kennoki · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.